Keyword: chemotherapy

News

Germany’s Merck Ends Bavencio Pact with Pfizer

05.04.2023 -

Germany’s Merck will regain exclusive worldwide rights to develop, manufacture and commercialize the anti-programmed death ligand-1 (PD-L1) antibody Bavencio (avelumab)...

News

Genentech Returns Cancer Drug Rights to NewLink

16.06.2017 - US biotechnology group Genentech, part of Roche, is handing back rights to NewLink Genetics’ IDO inhibitor GDC-0919 (navoximod), an investigational cancer treatment. Genentech...

News

FDA Approves NuvOx IND Brain Tumor Trial

18.04.2017 - The US Food and Drug Administration (FDA) has approved NuvOx Pharma’s application to proceed with Phase 2 clinical trials for an Investigational New Drug (IND) to initiate a Phase...

News

China Gets its First Generic Geftinib Drug

22.02.2017 - Chinese drugmaker Qilu Pharmaceutical has introduced a new targeted therapy generic cancer medicine, geftinib, which is claimed to be effective against non-small cell lung cancer...

News

FDA Halts Cancer Trial After Deaths

14.07.2016 - The US Food and Drug Administration has ordered Juno Therapeutics to suspend its Phase II immunotherapy trials with adult patients suffering from relapsed or refractory B cell...

News

Genentech’s Bladder Cancer Drug Wins US Approval

23.05.2016 - Genentech has won an accelerated approval from the US Food and Drug Administration (FDA) for bladder cancer treatment Tecentriq. The immunotherapy has been cleared to treat...

News

FDA Approves New Pancreatic Cancer Treatment

29.10.2015 - The US Food and Drug Administration (FDA) has approved, with reservations, the new pancreatic cancer drug Onivyde manufactured by US drugmaker Merrimack for use in combination with...

News

EU Approves Pfizer-Hospira Deal With Strings

06.08.2015 - European regulatory authorities have approved the $15.2 billion takeover of injectable drug and infusion device maker Hospira by US drugmaker Pfizer, subject to certain conditions...